Caris Precision Oncology Alliance™ Chairman, Dr. Chadi Nabhan, sits down with Dr. Michael Korn, Chief Medical Officer at Caris Life Sciences®, to discuss the MI FOLFOXai™ predictor of response to FOLFOX chemotherapy in metastatic colorectal cancer.
For more information, please visit: www.CarisLifeSciences.com/MI-FOLFOXai/
